Sophia Danhof

10PUBLICATIONS
29CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 22, 2023
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma.

Umair Munawar, Xiang Zhou, Sabrina Prommersberger

|Nov 24, 2023
BCMA CAR-T cells in multiple myeloma-ready for take-off?

Lukas Scheller, Erius Tebuka, Peter Fabian Rambau

|Jul 02, 2021
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer.

Maik Luu, Zeno Riester, Adrian Baldrich

|Feb 23, 2021
Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma.

Matteo C Da Vià, Oliver Dietrich, Marietta Truger

|Feb 12, 2021
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns.

Sophia Danhof, Leo Rasche, Anja Mottok

|May 01, 2020
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab.

Estefanía García-Guerrero, Ralph Götz, Sören Doose

Pageof 2

Frequent Collaborators

5 joint publications

Michael Hudecek

4 joint publications

Thomas Nerreter

4 joint publications

Hermann Einsele

3 joint publications

Leo Rasche